相关实验视频

Updated: Jan 18, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

慢性输血患者的红细胞改善输血 (RBC-IMPACT) 研究:国际多地点观察性临床研究的协议描述

Matthew S Karafin¹, Shannon Kelly², Kathleen M Chapman³

¹Department of Pathology and Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill, NC, USA.

Blood transfusion = Trasfusione del sangue

|May 27, 2025

概括

这项研究研究了影响慢性输血患者红细胞 (RBC) 输血有效性的因素. 了解供体,成分和受体的变异性是优化输血结果和安全的关键.

科学领域:

血液学血液学血液学
输血医学输血医学
遗传学是一个遗传学.

背景情况:

捐赠者,组件和接受者的变化影响了输血结果.
这些因素对输血有效性的综合影响仍然不清楚.
慢性输血治疗对于管理像沙拉西米亚和状细胞病 (SCD) 这样的疾病至关重要.

研究的目的:

为了研究慢性输血患者输血后红细胞 (RBC) 存活率.
为了评估输血后血清铁水平的急性变化.
确定用于优化RBC有效性和安全性的预测变量.

主要方法:

美国和巴西的多中心纵向研究 (RBC-IMPACT).
输血前和后收集血液样本,以测量血红蛋白,铁和血液溶解标志物.
利用单核酸多态性 (SNP) 阵列类型来分析捐赠者和接受者的遗传变异.

主要成果:

红细胞存活率的评估是使用SCD患者每天血红蛋白A (HbA) 的变化和thalassemia患者每天血红蛋白 (Hb) 的变化.
对这两组患者的胆红素水平进行了评估,以表明血液溶解.
铁的评估的主要结果是血清铁从输血前到输血后两个小时的变化.

结论:

本研究提供了对影响红细胞输血有效性的因素的详细评估.
这些发现将有助于优化慢性输血人群中红细胞的有效性和安全性.
了解捐赠者-接受者遗传相互作用对于个性化输血策略至关重要.

更多相关视频

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

相关概念视频

Blood Transfusion

Blood Transfusion

Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...

Blood Transfusion and Agglutination

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...